Andrew Taylor work email
- Valid
- Valid
- Valid
- Valid
Andrew Taylor personal email
Andrew Taylor phone numbers
Andrew Taylor is an experienced financial officer, operating executive, team builder and business advisor. Strategic planner and creative problem solver with strong leadership and communication skills. Proven record in public and private entrepreneurial start-up, emerging growth and Fortune 500 companies in the US and abroad. Developed and implemented corporate strategy initiatives and led M&A activity in various settings. Negotiated and secured wide-ranging equity and debt agreements. Extensive investor relations management and wide-ranging interaction and collaboration with Boards of Directors. Leadership in the areas of IPO, SEC, SOX and other compliance matters, and financial planning & analysis. Management of multiple financial audits and tax filings. Directed treasury, risk management and IT operations.Andrew Taylor joined Orchestra BioMed (NASDAQ: OBIO) as its Chief Financial Officer in June 2023 and brings over 20 years of CFO experience with emerging growth companies, the last 15 of which were in the medical device sector. Prior to joining Orchestra BioMed, Mr. Taylor served as CFO of Motus GI Holdings, Inc. (NASDAQ: MOTS), where he helped lead the company’s 2018 IPO. Prior to Motus GI, Mr. Taylor spent 10 years as CFO and President of Avertix Medical, Inc. (f/k/a Angel Medical Systems, Inc.), where he is still a member of the Board of Directors. Prior to Avertix, he was a Practice Leader for AC Lordi Consulting (now part of BDO USA, LLP) and CFO and Corporate Director of Operations for Safe3w, Inc. (acquired by iPass). Mr. Taylor earned a high-honors MBA with a concentration in Accounting and Finance from Northeastern University and a B.A. in Political Science and Economics from McGill University.
-
Chief Financial OfficerOrchestra Biomed Jun 2023 - PresentOrchestra BioMed (Nasdaq: OBIO) is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies. Orchestra BioMed’s partnership-enabled business model focuses on forging strategic collaborations with leading medical device companies to drive successful global commercialization of products it develops. Orchestra BioMed’s flagship product candidates include BackBeat Cardiac Neuromodulation Therapy™ (CNT™) for the treatment of hypertension, a significant risk factor for death worldwide, and Virtue® Sirolimus AngioInfusion™ Balloon (SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. Orchestra BioMed has a strategic collaboration with Medtronic, one of the largest medical device companies in the world, for development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients, and a strategic partnership with Terumo Corporation, a global leader in medical technology, for development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed has additional product candidates and plans to potentially expand its product pipeline through acquisitions, strategic collaborations, licensing, and organic development -
Board Of Directors, MemberAvertix Medical Aug 2017 - Sep 2024Us -
President & Chief Financial OfficerAvertix Medical Dec 2007 - Aug 2017UsVenture and strategic backed medtech / digital health company with operations in US and Asia. PMA approved implantable ACS detection and patient alerting device.
-
Chief Financial OfficerMotus Gi Holdings, Inc. Aug 2017 - Jun 2023Fort Lauderdale, Fl, UsMotus GI Holdings, Inc., (NASDAQ: MOTS) is a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions. -
Fractional Strategic Cfo ConsultingHale.Life Feb 2017 - Aug 2017Precision medicine & wellness company
-
Fractional Strategic Cfo ConsultingGenome Profiling, Llc Aug 2016 - Aug 2017Epigenetic biomarker discovery and quantitative analysis
-
Practice Leader – Business Advisory ServicesAc Lordi Consulting (Acquired By Bdo Usa, Llp) Jul 2006 - Dec 2007Top regional accounting and business advisory services firm
-
Chief Financial OfficerSafe3W, Inc. (Acquired By Ipass, Inc.) Dec 2001 - Jan 2005Security software company acquired by network services provider, iPass, Inc. (NASDAQ: IPAS)
Andrew Taylor Skills
Andrew Taylor Education Details
-
D'Amore-Mckim School Of Business At Northeastern UniversityAccounting & Finance -
Mcgill UniversityPolitical Science & Economics
Frequently Asked Questions about Andrew Taylor
What company does Andrew Taylor work for?
Andrew Taylor works for Orchestra Biomed
What is Andrew Taylor's role at the current company?
Andrew Taylor's current role is Chief Financial Officer.
What is Andrew Taylor's email address?
Andrew Taylor's email address is an****@****sgi.com
What is Andrew Taylor's direct phone number?
Andrew Taylor's direct phone number is +126732*****
What schools did Andrew Taylor attend?
Andrew Taylor attended D'amore-Mckim School Of Business At Northeastern University, Mcgill University.
What skills is Andrew Taylor known for?
Andrew Taylor has skills like Mergers And Acquisitions, Start Ups, Financial Modeling, Strategic Planning, Finance, Financial Analysis, Due Diligence, Business Strategy, Forecasting, Risk Management, Mergers, Accounting.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial